AC |
Aminocaproic acid |
ACVRL1/ALK1 |
Activin Receptor-Like Kinase 1 |
AVM |
Arteriovenous Malformation |
BMP9 |
Bone Morphogenetic Protein 9 |
BZ |
Bevacizumab |
CM |
Capillary Malformation |
CYP2D6 |
Cytochrome P450 2D6 |
ECs |
Endothelial Cells |
EMA |
European Medicine Agency |
ENG |
Endoglin |
EPHB4 |
Ephrin Type-B Receptor 4 |
ER |
Estrogen Receptor |
ESS |
Epistaxis Severity Score |
FDA |
Food and Drug Administration |
FGF |
Fibroblast Growth Factor |
FK506 |
Tacrolimus |
GI |
Gastrointestinal |
HHT |
Hereditary Hemorrhagic Telangiectasia |
iKO |
inducible Knockout |
JPHT |
Juvenile Polyposis/HHT |
MADH4/Smad4 |
Mothers Against Decapentaplegic Homolog 4 |
mRNA |
messenger Ribonucleic Acid |
NAC |
N-acetylcysteine |
OLT |
Orthotopic Liver Transplant |
OPG |
Osteoprotegerin |
PDGF |
Platelet Derived Growth Factor |
RANK |
Receptor Activator of Nuclear Factor κ B |
RANK-L |
Receptor Activator of Nuclear Factor κ B Ligand |
RASA1 |
RAS P21 Protein Activator 1 |
SERMs |
Selective Estrogen Receptor Modulator |
TA |
Tranexamic Acid |
TFRE |
Transcription Factor Regulatory Element |
TGF-β |
Transforming Growth Factor β |
VEGF |
Vascular Endothelial Growth Factor |
VM |
Venous Malformation |